RE: Pharmacokinetics, allometry and flat earth theories

From: Vladimir Piotrovskij Date: October 15, 2001 technical Source: cognigencorp.com
From: "Piotrovskij, Vladimir [JanBe]" <VPIOTROV@janbe.jnj.com> Subject: RE: Pharmacokinetics, allometry and flat earth theories Date: Mon, 15 Oct 2001 10:15:08 +0200 I totally agree with Nick and Paul that using BSA for dose scaling has no scientific rationale. Though I am not sure using a factor of WT^0.75 in dose calculation is really necessary in adult population, BSA scaling should be certainly avoided as it may result in wrong individual dose prescription. Best regards, Vladimir ------------------------------------------------------------------------ Vladimir Piotrovsky, Ph.D. Research Fellow Advanced Modelling and Simulations Global Clinical Pharmacokinetics and Clinical Pharmacology (ext. 5463) Janssen Research Foundation B-2340 Beerse Belgium
Oct 04, 2001 Nick Holford Pharmacokinetics, allometry and flat earth theories
Oct 04, 2001 Paul Hutson Re: Pharmacokinetics, allometry and flat earth theories
Oct 15, 2001 Vladimir Piotrovskij RE: Pharmacokinetics, allometry and flat earth theories